Gil Blum
Stock Analyst at Needham
(3.89)
# 666
Out of 5,111 analysts
419
Total ratings
41.56%
Success rate
12.99%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Gil Blum
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABSI Absci | Reiterates: Buy | $7 | $3.39 | +106.49% | 7 | Dec 12, 2025 | |
| AUTL Autolus Therapeutics | Reiterates: Buy | $10 | $1.62 | +517.28% | 32 | Dec 12, 2025 | |
| NRIX Nurix Therapeutics | Reiterates: Buy | $26 | $19.01 | +36.77% | 28 | Dec 8, 2025 | |
| ACLX Arcellx | Reiterates: Buy | $105 | $68.34 | +53.64% | 24 | Dec 8, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $81 → $80 | $56.25 | +42.22% | 26 | Nov 10, 2025 | |
| CELC Celcuity | Reiterates: Buy | $70 | $102.18 | -31.49% | 21 | Oct 20, 2025 | |
| ARTV Artiva Biotherapeutics | Reiterates: Buy | $18 | $6.30 | +185.71% | 7 | Oct 17, 2025 | |
| MREO Mereo BioPharma Group | Maintains: Buy | $7 → $5 | $2.19 | +128.31% | 19 | Jul 10, 2025 | |
| IMCR Immunocore Holdings | Reiterates: Buy | $71 | $36.02 | +97.11% | 14 | Apr 10, 2025 | |
| GERN Geron | Reiterates: Buy | $5 | $1.33 | +275.94% | 23 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $5.71 | +180.21% | 1 | Dec 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Suspends: Buy | $15 | $5.39 | +178.29% | 19 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $6 | $0.96 | +523.18% | 8 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $1.12 | - | 9 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $5.76 | +73.61% | 31 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $14 | $10.88 | +28.68% | 7 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $4.20 | +90.48% | 25 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.84 | +443.48% | 18 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Underperform | n/a | $21.55 | - | 38 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | n/a | $3.41 | - | 22 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $40 | $8.97 | +345.93% | 15 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $3.06 | - | 16 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $48 | $11.47 | +318.48% | 9 | Aug 2, 2024 |
Absci
Dec 12, 2025
Reiterates: Buy
Price Target: $7
Current: $3.39
Upside: +106.49%
Autolus Therapeutics
Dec 12, 2025
Reiterates: Buy
Price Target: $10
Current: $1.62
Upside: +517.28%
Nurix Therapeutics
Dec 8, 2025
Reiterates: Buy
Price Target: $26
Current: $19.01
Upside: +36.77%
Arcellx
Dec 8, 2025
Reiterates: Buy
Price Target: $105
Current: $68.34
Upside: +53.64%
CRISPR Therapeutics AG
Nov 10, 2025
Maintains: Buy
Price Target: $81 → $80
Current: $56.25
Upside: +42.22%
Celcuity
Oct 20, 2025
Reiterates: Buy
Price Target: $70
Current: $102.18
Upside: -31.49%
Artiva Biotherapeutics
Oct 17, 2025
Reiterates: Buy
Price Target: $18
Current: $6.30
Upside: +185.71%
Mereo BioPharma Group
Jul 10, 2025
Maintains: Buy
Price Target: $7 → $5
Current: $2.19
Upside: +128.31%
Immunocore Holdings
Apr 10, 2025
Reiterates: Buy
Price Target: $71
Current: $36.02
Upside: +97.11%
Geron
Apr 11, 2024
Reiterates: Buy
Price Target: $5
Current: $1.33
Upside: +275.94%
Dec 4, 2025
Initiates: Buy
Price Target: $16
Current: $5.71
Upside: +180.21%
Nov 7, 2025
Suspends: Buy
Price Target: $15
Current: $5.39
Upside: +178.29%
Nov 4, 2025
Maintains: Buy
Price Target: $9 → $6
Current: $0.96
Upside: +523.18%
Oct 27, 2025
Reiterates: Hold
Price Target: n/a
Current: $1.12
Upside: -
Oct 17, 2025
Reiterates: Buy
Price Target: $10
Current: $5.76
Upside: +73.61%
Sep 18, 2025
Upgrades: Buy
Price Target: $14
Current: $10.88
Upside: +28.68%
Sep 11, 2025
Reiterates: Buy
Price Target: $8
Current: $4.20
Upside: +90.48%
Aug 13, 2025
Reiterates: Buy
Price Target: $10
Current: $1.84
Upside: +443.48%
Jul 29, 2025
Reiterates: Underperform
Price Target: n/a
Current: $21.55
Upside: -
Jul 24, 2025
Maintains: Hold
Price Target: n/a
Current: $3.41
Upside: -
May 8, 2025
Maintains: Buy
Price Target: $41 → $40
Current: $8.97
Upside: +345.93%
Mar 27, 2025
Reiterates: Hold
Price Target: n/a
Current: $3.06
Upside: -
Aug 2, 2024
Reiterates: Buy
Price Target: $48
Current: $11.47
Upside: +318.48%